Compared to neurologically healthy controls, Wilcoxon tests showed that plasma GFAP was higher in αSyn+AD (W = 229, P = 0.000013) and AD groups (W = 174, P = 1.3e‐07), but not αSyn (W = 761.5, P = 0.052). This evidence concerns the gene GFAP and Alzheimer disease.